SpectraCure AB Year-end report 1 January – 31 December 2018
Fourth quarter (1 October – 31 December 2018) · Net sales for the quarter amounted to TSEK 0 (0). · Operating profit (EBIT) was TSEK -3 249 (-2 599). · Operating cash flow was TSEK -3 806 (-2 632). · Profit after tax amounted to TSEK -3 242 (-2 599). · Corresponding to SEK -0,04 (-0,04) per share. Full-year (1 January – 31 December 2018) · Net sales for the period amounted to MSEK 0 (0). · Operating profit (EBIT) was TSEK -11 821 (-8 535). · Operating cash flow was TSEK -10 864 (-9 095). · Profit after tax amounted to TSEK -11 814 (-8 535). ·